Schedule 13G ownership disclosure

NEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 64052L106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,104,146
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-18-007272
Form type
SC 13G
Filer
BlackRock Finance, Inc.
CIK
CIK 1364742
Filed
Dec 07, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub